1
|
Lunsing RJ, Strating K, de Koning TJ and
Sijens PE: Diagnostic value of MRS-quantified brain tissue lactate
level in identifying children with mitochondrial disorders. Eur
Radiol. 27:976–984. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kirby DM and Thorburn DR: Approaches to
finding the molecular basis of mitochondrial oxidative
phosphorylation disorders. Twin Res Hum Genet. 11:395–411. 2008.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Kohda M, Tokuzawa Y, Kishita Y, Nyuzuki H,
Moriyama Y, Mizuno Y, Hirata T, Yatsuka Y, Yamashita-Sugahara Y,
Nakachi Y, et al: A comprehensive genomic analysis reveals the
genetic landscape of mitochondrial respiratory chain complex
deficiencies. PLoS Genet. 12:e10056792016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Debray FG, Lambert M, Chevalier I,
Robitaille Y, Decarie JC, Shoubridge EA, Robinson BH and Mitchell
GA: Long-term outcome and clinical spectrum of 73 pediatric
patients with mitochondrial diseases. Pediatrics. 119:722–733.
2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pinto M, Pickrell AM and Moraes CT:
Regional susceptibilities to mitochondrial dysfunctions in the CNS.
Biol Chem. 393:275–281. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Turconi AC, Benti R, Castelli E,
Pochintesta S, Felisari G, Comi G, Gagliardi C, Del Piccolo L and
Bresolin N: Focal cognitive impairment in mitochondrial
encephalomyopathies: A neuropsychological and neuroimaging study. J
Neurol Sci. 170:57–63. 1999. View Article : Google Scholar : PubMed/NCBI
|
7
|
Palmieri L and Persico AM: Mitochondrial
dysfunction in autism spectrum disorders: Cause or effect? Biochim
Biophys Acta. 1797:1130–1137. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Rahman S: Mitochondrial disease and
epilepsy. Dev Med Child Neurol. 54:397–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Khurana DS, Salganicoff L, Melvin JJ,
Hobdell EF, Valencia I, Hardison HH, Marks HG, Grover WD and Legido
A: Epilepsy and respiratory chain defects in children with
mitochondrial encephalopathies. Neuropediatrics. 39:8–13. 2008.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Bindoff LA and Engelsen BA: Mitochondrial
diseases and epilepsy. Epilepsia. 53 Suppl 4:92–97. 2012.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Wolf NI, Rahman S, Schmitt B, Taanman JW,
Duncan AJ, Harting I, Wohlrab G, Ebinger F, Rating D and Bast T:
Status epilepticus in children with Alpers' disease caused by POLG1
mutations: EEG and MRI features. Epilepsia. 50:1596–1607. 2009.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Rahman S: Pathophysiology of mitochondrial
disease causing epilepsy and status epilepticus. Epilepsy Behav.
49:71–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Martikainen MH, Ng YS, Gorman GS, Alston
CL, Blakely EL, Schaefer AM, Chinnery PF, Burn DJ, Taylor RW,
McFarland R and Turnbull DM: Clinical, genetic, and radiological
features of extrapyramidal movement disorders in mitochondrial
disease. JAMA Neurol. 73:668–674. 2016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Lax NZ, Hepplewhite PD, Reeve AK, Nesbitt
V, McFarland R, Jaros E, Taylor RW and Turnbull DM: Cerebellar
ataxia in patients with mitochondrial DNA disease: A molecular
clinicopathological study. J Neuropathol Exp Neurol. 71:148–161.
2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Giordano C, Pichiorri F, Blakely EL, Perli
E, Orlandi M, Gallo P, Taylor RW, Inghilleri M and d'Amati G:
Isolated distal myopathy of the upper limbs associated with
mitochondrial DNA depletion and polymerase gamma mutations. Arch
Neurol. 67:1144–1146. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhu CC, Traboulsi EI and Parikh S:
Ophthalmological findings in 74 patients with mitochondrial
disease. Ophthalmic Genet. 38:67–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Grönlund MA, Honarvar AK, Andersson S,
Moslemi AR, Oldfors A, Holme E, Tulinius M and Darin N:
Ophthalmological findings in children and young adults with
genetically verified mitochondrial disease. Br J Ophthalmol.
94:121–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Leber T: Ueber hereditäre und
congenital-angelegte Sehnervenleiden. Albrecht Von Graefes Arch
Ophthalmol. 17:249–291. 1871. View Article : Google Scholar
|
19
|
Newman NJ: Leber's hereditary optic
neuropathy. New genetic considerations. Arch Neurol. 50:540–548.
1993. View Article : Google Scholar : PubMed/NCBI
|
20
|
Cormier-Daire V, Chretien D, Rustin P,
Rötig A, Dubuisson C, Jacquemin E, Hadchouel M, Bernard O and
Munnich A: Neonatal and delayed-onset liver involvement in
disorders of oxidative phosphorylation. J Pediatr. 130:817–822.
1997. View Article : Google Scholar : PubMed/NCBI
|
21
|
Rahman S: Gastrointestinal and hepatic
manifestations of mitochondrial disorders. J Inherit Metab Dis.
36:659–673. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Garone C, Tadesse S and Hirano M: Clinical
and genetic spectrum of mitochondrial neurogastrointestinal
encephalomyopathy. Brain. 134:3326–3332. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hirano M, Nishigaki Y and Martí R:
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): A
disease of two genomes. Neurologist. 10:8–17. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Spiegler J, Stefanova I, Hellenbroich Y
and Sperner J: Bowel obstruction in patients with
Alpers-Huttenlocher syndrome. Neuropediatrics. 42:194–196. 2011.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Crippa BL, Leon E, Calhoun A, Lowichik A,
Pasquali M and Longo N: Biochemical abnormalities in Pearson
syndrome. Am J Med Genet A. 167A:1–628. 2015.PubMed/NCBI
|
26
|
Chow J, Rahman J, Achermann JC, Dattani MT
and Rahman S: Mitochondrial disease and endocrine dysfunction. Nat
Rev Endocrinol. 13:92–104. 2017. View Article : Google Scholar : PubMed/NCBI
|
27
|
Maechler P: Mitochondrial function and
insulin secretion. Mol Cell Endocrinol. 379:12–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Karaa A and Goldstein A: The spectrum of
clinical presentation, diagnosis, and management of mitochondrial
forms of diabetes. Pediatr Diabetes. 16:1–9. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Martín-Hernández E, García-Silva MT, Vara
J, Campos Y, Cabello A, Muley R, Del Hoyo P, Martín MA and Arenas
J: Renal pathology in children with mitochondrial diseases. Pediatr
Nephrol. 20:1299–1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
Holmgren D, Wåhlander H, Eriksson BO,
Oldfors A, Holme E and Tulinius M: Cardiomyopathy in children with
mitochondrial disease; clinical course and cardiological findings.
Eur Heart J. 24:280–288. 2003. View Article : Google Scholar : PubMed/NCBI
|
31
|
Finsterer J and Kothari S: Cardiac
manifestations of primary mitochondrial disorders. Int J Cardiol.
177:754–763. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Gold M and Rapin I: Non-Mendelian
mitochondrial inheritance as a cause of progressive genetic
sensorineural hearing loss. Int J Pediatr Otorhinolaryngol.
30:91–104. 1994. View Article : Google Scholar : PubMed/NCBI
|
33
|
Cavanagh JB and Harding BN: Pathogenic
factors underlying the lesions in Leigh's disease. Tissue responses
to cellular energy deprivation and their clinico-pathological
consequences. Brain. 117:1357–1376. 1994. View Article : Google Scholar : PubMed/NCBI
|
34
|
Åkebrand R, Andersson S, Honarvar AK
Seyedi, Sofou K, Darin N, Tulinius M and Grönlund MA:
Ophthalmological characteristics in children with Leigh syndrome –
A long-term follow-up. Acta Ophthalmol. 94:609–617. 2016.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Lake NJ, Compton AG, Rahman S and Thorburn
DR: Leigh syndrome: One disorder, more than 75 monogenic causes.
Ann Neurol. 79:190–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
36
|
Khan A, Trevenen C, Wei XC, Sarnat HB,
Payne E and Kirton A: Alpers syndrome: The natural history of a
case highlighting neuroimaging, neuropathology, and fat metabolism.
J Child Neurol. 27:636–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Isohanni P, Hakonen AH, Euro L, Paetau I,
Linnankivi T, Liukkonen E, Wallden T, Luostarinen L, Valanne L,
Paetau A, et al: POLG1 manifestations in childhood. Neurology.
76:811–815. 2011. View Article : Google Scholar : PubMed/NCBI
|
38
|
Anagnostou ME, Ng YS, Taylor RW and
McFarland R: Epilepsy due to mutations in the mitochondrial
polymerase gamma (POLG) gene: A clinical and molecular genetic
review. Epilepsia. 57:1531–1545. 2016. View Article : Google Scholar : PubMed/NCBI
|
39
|
Haas RH, Parikh S, Falk MJ, Saneto RP,
Wolf NI, Darin N and Cohen BH: Mitochondrial disease: A practical
approach for primary care physicians. Pediatrics. 120:1326–1333.
2007. View Article : Google Scholar : PubMed/NCBI
|
40
|
Dinopoulos A, Cecil KM, Schapiro MB,
Papadimitriou A, Hadjigeorgiou GM, Wong B, deGrauw T and Egelhoff
JC: Brain MRI and proton MRS findings in infants and children with
respiratory chain defects. Neuropediatrics. 36:290–301. 2005.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Haas RH, Parikh S, Falk MJ, Saneto RP,
Wolf NI, Darin N, Wong LJ, Cohen BH and Naviaux RK: Mitochondrial
Medicine Society's Committee on Diagnosis: The in-depth evaluation
of suspected mitochondrial disease. Mol Genet Metab. 94:16–37.
2008. View Article : Google Scholar : PubMed/NCBI
|
42
|
Sim KG, Hammond J and Wilcken B:
Strategies for the diagnosis of mitochondrial fatty acid
beta-oxidation disorders. Clin Chim Acta. 323:37–58. 2002.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Larsson NG and Oldfors A: Mitochondrial
myopathies. Acta Physiol Scand. 171:385–393. 2001. View Article : Google Scholar : PubMed/NCBI
|
44
|
Yamamoto M, Koga Y, Ohtaki E and Nonaka I:
Focal cytochrome c oxidase deficiency in various neuromuscular
diseases. J Neurol Sci. 91:207–213. 1989. View Article : Google Scholar : PubMed/NCBI
|
45
|
Zhang M, Si Y and Zhao J: Characteristics
of molecular genetics and research progress on mitochondrial
diseases. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 33:717–725. 2016.(In
Chinese). PubMed/NCBI
|
46
|
Hsu YC, Chen CT and Wei YH: Mitochondrial
resetting and metabolic reprogramming in induced pluripotent stem
cells and mitochondrial disease modeling. Biochim Biophys Acta.
1860:686–693. 2016. View Article : Google Scholar : PubMed/NCBI
|
47
|
Ferreira A, Serafim TL, Sardão VA and
Cunha-Oliveira T: Role of mtDNA-related mitoepigenetic phenomena in
cancer. Eur J Clin Invest. 45 Suppl 1:44–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
48
|
Stranneheim H and Wedell A: Exome and
genome sequencing: A revolution for the discovery and diagnosis of
monogenic disorders. J Intern Med. 279:3–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
49
|
Yang Y, Muzny DM, Reid JG, Bainbridge MN,
Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, et al:
Clinical whole-exome sequencing for the diagnosis of mendelian
disorders. N Engl J Med. 369:1502–1511. 2013. View Article : Google Scholar : PubMed/NCBI
|
50
|
Faivre L, Cormier-Daire V, Chrétien D, von
Kleist-Retzow J Christoph, Amiel J, Dommergues M, Saudubray JM,
Dumez Y, Rötig A, Rustin P and Munnich A: Determination of enzyme
activities for prenatal diagnosis of respiratory chain deficiency.
Prenat Diagn. 20:732–737. 2000. View Article : Google Scholar : PubMed/NCBI
|